Martin is an Associate at Osage University Partners, a venture capital firm focused on investing in early and late stage university spinouts. Prior to joining Osage, Martin conducted research in the area of DNA repair at the Sloan-Kettering Institute and in thombin activation at the Children's Hospital of Philadelphia. Martin holds an MA in Biotechnology from Columbia University, and a BA in Economics from the University of Pennsylvania.